Pharma major Dr Reddy's Laboratories has launched Duloxetine delayed release capsules in the US market. The anti-depressant drug is the generic equivalent of Cymbalta.
The brand and generic had a sales of $5 billion in the US in the 12 months ended April 2014, according to a release. The company’s scrip gained 1.93 per cent on the BSE on Friday to close at ₹2553.15.